drugset / Trial / NCT00239954

Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder

NCT00239954

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness, safety and tolerability of an escitalopram combination treatment compared to single treatments, and to placebo in patients with major depressive disorder.

Timeline

Start
2005-03
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule